‘Form panel to test Siddha doctor’s herbal concoction’

June 23, 2020 09:07 pm | Updated 09:07 pm IST

Madurai

The Madurai Bench of the Madras High Court on Tuesday directed the Directorate of Indian Medicine and Homeopathy to constitute a committee of experts to test the herbal concoction prepared by a Madurai-based Siddha doctor to see if it could be a cure for COVID-19.

A Division Bench of Justices P.N. Prakash and B. Pugalendhi directed S. Subramanian of Madurai, the Siddha doctor to appear before the committee on June 26 at 10 a.m. and submit the medicine prepared by him with information regarding the ingredients and preparation.

If the expert committee were of the opinion that the medicine would be efficacious, they may refer it to the Central Council for Research in Ayurveda and Siddha (CCRAS), New Delhi, the court said and adjourned the hearing to June 30.

The court was hearing the petition filed by Siddha Doctor, Subramanian, currently working as Medical Officer in the Government Siddha Medical College in Palayamkottai. He was previously Medical Officer of the Siddha dispensary at the High Court Bench.

He filed the petition before the court seeking a direction to the Ministry of Ayush to test his herbal concoction to see if it could be a cure for COVID-19. He said his concoction, ‘IMPRO’, a mixture of 66 herbs would increase immunity.

The court observed that under normal circumstances, it would not have entertained the petition as it would open the floodgate for a number of such petitions. The plea was taken up for hearing on the sole ground that the petitioner was a qualified Siddha doctor, the court said.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.